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Abstract
Background: Falls are detrimental to people with Parkinson’s Disease (PD)
because of the potentially severe consequences to the patients’ quality of life.
Thus, identifying factors that predict falls is necessary. While many stud-
ies have attempted to predict falls/non-falls, this study aimed to determine
factors related to falls frequency in people with early Parkinson’s disease
(PD).
Methods: 99 participants with early-stage PD were assessed based on two
types of tests. The first type of tests is disease-specific tests, comprised of
the Unified Parkinson’s Disease Rating Scale (UPDRS) and the Schwab and
England activities of daily living scale (SE ADL). A measure of postural
instability and gait disorder (PIGD) and subtotal scores for subscales I, II,
and III were derived from the UPDRS. The second type of tests is functional
tests, including Tinetti gait and balance, Berg Balance Scale (BBS), Timed
Up and Go (TUG), Functional Reach (FR), Freezing of Gait (FOG), Mini
Mental State Examination (MMSE), and Melbourne Edge Test (MET). Falls
were recorded each month for 6 months. Clustering of patients via Finite
Mixture Model (FMM) was conducted.
Results: Three clusters of patients were found: non-or single-fallers, low fre-
quency fallers, and high frequency fallers. We identify several factors that are
important to clustering PD patients. For the disease specific measures, UP-
DRS subscales II and III subtotals, PIGD and SE ADL are able to differenti-
ate PD patients in non-or single-fallers from low frequency fallers. However,
Preprint submitted to arXiv October 7, 2019
ar
X
iv
:1
91
0.
01
86
4v
1 
 [s
tat
.A
P]
  4
 O
ct 
20
19
these factors could not differentiate PD patients with low frequency fallers
from high frequency fallers. While for functional tests measures, Tinetti,
TUG, and BBS turned to be important factors in clustering PD patients,
and could differentiate the three clusters. When comparing the predictive
ability of each factor to assigning new patients into cluster, factors from dis-
ease specific measures showed a stronger association with clusters than that
of functional test measures. This means that disease specific measures are
more informative than functional tests in explaining PD patients condition.
Yet, for clustering patients with recurrent falls, functional tests complement
the information from disease specific measures.
Conclusions: FMM is able to cluster people with PD into three groups.
We obtain several factors important to explaining the clusters and also found
different role of disease specific measures and functional tests to clustering
PD patients. Upon examining these measures, it might be possible to develop
new disease treatment to prevent, or to delay, the occurrence of falls.
Keywords: Falls prediction, functional tests, finite mixture model, Poisson,
recurrent falls, cluster, UPDRS.
1. Introduction
Falls are common in people with Parkinson’s disease (PD), and can have
an enormous impact on the physical and psychological health such as injury
[5, 12], reduced activity levels [5] and poor quality of life [4, 34]. A review
of prospective studies reported that 45% to 68% of patients fell at least once
within a 6- to 12-month period [17, 28, 42]. Moreover, it was also reported
that patients experiencing falls are more likely to fall again [29, 42]. These
findings highlight the importance of identifying fall risk factors to further aid
clinicians design tailored treatment options to reduce falls.
Many studies have been conducted to model falls in PD, with the attempt
to discriminate fallers from non-fallers based on various measurements (see
for example [6, 8, 11, 19, 22]). However, PD is progressive. Movement
control becomes more debilitating over time, as the patient experiences more
tremors, rigid muscles, slow movement and difficulty balancing [24]. It is
plausible to hypothesize that patients might experience falls more frequently
as the disease progresses. While previous studies have looked at fallers/non-
fallers, this study focuses on falls frequency, with the aim to identify risk
factors associated with falls frequency.
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There have also been many studies aimed at classifying PD into sev-
eral subtypes. Using data driven techniques, researchers have recommended
several ways of subgrouping (subtypes), with the numbers of subtypes rang-
ing from 2 to 5 [7, 10, 13, 18, 20, 30, 32, 36, 40, 41]. The methods pro-
posed include discriminant analysis [40, 10], K-means clustering [20], and
empirical assignment, mostly based on tremor dominance versus non-tremor
dominance. Using these various methods, patients were assigned to a fixed
subgroup (subtype).
While there have been many such studies, the implementation of PD sub-
types in clinical research studies has been very limited [23]. It is argued that
in order to be useful, the subtypes should be able to explain the disease ae-
tiology, prognosis or treatment responsiveness [23], and should be associated
with the disease progression.
In response to this, we consider fall frequency as a measure of disease
progression in addition to other clinical assessments for profiling subgroups
of PD patients. Furthermore, considering the clinically highly heterogeneous
characteristics of PD [18, 15, 9, 23], a stochastic assignment of individuals
into subgroups seems more suitable than a fixed subgroup assignment, as was
done in the studies previously described. This can be addressed using finite
mixture models (FMMs). Subgrouping subjects based on some covariates
via the FMMs, in tandem with the associated risk factor, is known as profile
regression [26, 21].
A mixture model is an effective method of analysis in order to gain in-
sight into patient groupings as it facilitates the identification of different
sub-populations (subgroups) and their characteristics. The application of
mixture models for subgrouping has a number of advantages: it quantifies
the uncertainty of a patient’s assignment into a given subgroup, profiles for
the subgroups found can be generated using the estimated model, and it
provides a statistically rigorous way of determining the number of subgroups
[25]. Examples of FMM implementation in PD studies are as demonstrated
in [33] and [41] for the identification of PD phenotype based on symptoms.
As our main interest is to find subgroups of patients that have similar
profiles with regard to disease progression, incorporating fall frequency eases
the interpretation of the subgroups produced. For example, the subgroup
with a high frequency of falls is considered to be a high risk group. The
characteristics of each subgroup are generated by important factors govern-
ing the subgroups and provide information on the fall risk factors. Further,
upon examining these characteristics, it may be possible to develop interven-
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tions to slow the progression of PD. To the best of our knowledge, this is
the first study in PD that has implemented FMMs for patient subgrouping
incorporating fall frequency.
The aim of this paper is to identify risk factors related to falls frequency
in people with early stages of PD using profile regression model. The focus
is twofold: (i) profile generation of clusters of patients based on the disease-
specific and functional tests measures which in the end, the optimal combi-
nation of those measures can be inferred to explain falls frequency and (ii)
comparing the role of disease specific tests and functional tests in assigning
patients into clusters.
The remainder of this paper is organized as follows. A description of
data and methodology are provided in Section 2. Key results are presented
in Section 3, including a comparison between disease-specific measures and
functional tests measures to determine the patients clustering, and generating
the patients clusters profiles. A discussion of results and limitations are
presented in Section 4. Finally, summary of overall findings is given in Section
5.
2. Data and Methods
2.1. Data
Participants. 101 people diagnosed with idiopathic PD participated in a
prospective study conducted from March 2002 until December 2006. Partic-
ipants were recruited from community support groups and neurology clinics
in southeast Queensland, as a part of a larger research project conducted
by the Institute of Health and Biomedical Innovation in Brisbane, Australia
[16]. All participants were classified as early stage PD, determined by a
Hoehn and Yahr (HY) score of 3 or less. Two patients with extremely high
frequency of falls were excluded, giving a total of 99 patients data for the
analysis.
Assessments. Each participant was followed up for a consecutive six month
period with a monthly record of falls. Participants were classified as fallers if
they recorded any falls during follow-up. Successful completion of falls diary
was monitored by phone calls and mail correspondence.
A series of clinical and functional tests were conducted at baseline. Par-
ticipants were assessed based on two types of tests: disease specific tests and
functional tests. The disease specific tests consist of the Unified Parkinson’s
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Disease Rating Scale (UPDRS) and the Schwab and England activities of
daily living scale (SE ADL). The UPDRS was assessed for three subscales: I
(mentation, behaviour, mood), II (activities of daily living), and III (motor
function). A measure of postural instability and gait disability (PIGD) was
derived from the UPDRS (sum of items 13 - 15, 27 - 30). Sums of items in
each of the UPDRS subscales yielded subtotals 1, 2, and 3, correspondingly.
The functional tests consist of Tinetti (comprised of 2 subscales which relate
to a clinical balance and gait), Berg Balance Scale (BBS), Timed Up and Go
(TUG), Functional Reach (FR) and Freezing of Gait (FOG) for balance and
gait, Mini Mental State Examination (MMSE) for cognitive impairment, and
Melbourne Edge Test (MET) for visual acuity.
2.2. Statistical methods
2.2.1. Profile regression
Data on n patients are denoted by D = {d1, ..., dn}, where di, the data
of patient i, consists of P measurements based on assessments related to the
disease, xi = (xi1, ..., xiP ), and fall frequency yi. Each of the assessments j,
x.j, is assumed to follow a Gaussian distribution with mean µj and variance
σ2j , that is x.j ∼ N(xj|µj, σ2j ), for j = 1, ..., P . Fall frequency, yi, is assumed
to follow a Poisson distribution with mean θ, yi ∼ Po(θ). Assume that
patients belong toK sub-populations, hereafter called subgroups. For patient
i, the mixture model for the covariates is given by
f(xi|pi,µ,Σ) =
K∑
k=1
pikNP (xi|µk,Σk) i = 1, ..., n, (1)
where NP (.) is the p-dimensional Gaussian density, pi = {pik}Kk=1 are the
mixing proportions, interpreted as the probability of assigning patient i with
the specified criteria xi into subgroup k. As proportions, each pik lies between
0 and 1 and
∑
k pik = 1. If patient i belongs to subgroup k, then µk =
(µ1k, ..., µPk)
T is the mean vector of xi with the covariance matrix of Σk. We
assume variables are independent with a constant variance across each of the
subgroups, that is, Σk = diag(σ
2
1, ..., σ
2
P ).
The assignment of each patient to one of the subgroups is of interest. For
this purpose, a latent variable zi such that
xi|zi = k ∼ N(xi|µk,Σk), (2)
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is introduced to identify the subgroup from which each patient has been gen-
erated. This latent variable is considered as missing data, and is to be esti-
mated as part of the model. By incorporating this latent variable, it provides
an alternative interpretation of the component weights, pik = Pr(zi = k),
that is pik is the probability that object i is assigned to subgroup k. This
implies that a multinomial distribution with parameter pi = (pi1, ..., piK) is
specified for zi.
Given the response data (i.e. fall frequency), the joint covariate and
response model for patient i is then given by,
f(xi, yi|pi,µ,Σ, θ) =
K∑
k=1
pikN(xi|µk,Σk)Po(yi|θk) i = 1, ..., n, (3)
where the response yi follows a Poisson distribution with mean θ (which takes
value θ = θk if patient i is assigned to subgroup k).
The association of the profiles and the response is characterized by
log(θi|zi) = γzi + βui, (4)
where β = (β1, ..., βH) denotes the regression parameter coefficients asso-
ciated with the covariates ui = (ui1, ..., uiH), γzi being an individual-level
intercept. In this paper, no covariates ui are assumed to affect fall count,
and thus the model in Equation (4) reduces to
log(θi|zi) = γzi , (5)
and thus γzi denotes the mean fall count (in a logarithm scale) for patient i
if he or she belongs to subgroup zi. Hence, the likelihood for all patients is
f(x, y|pi,µ,Σ, θ) =
n∏
i=1
K∑
k=1
pikN(xi|µk,Σk)Po(yi|θk). (6)
If the subgroup assignment is known, then the complete data likelihood is
given by,
f(x, y|pi,µ,Σ, θ) =
n∏
i=1
piziN(xi|µzi ,Σzi)Po(yi|θzi). (7)
The model states that the patients, based on their symptoms represented
by clinical measurements x and fall frequency y, are generated from K dis-
tinct random processes representing the K subgroups. Each of the processes
is described by its own distributions, N(x|µk,Σk) and Po(y|θk).
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We wish to make Bayesian inference for the model parameters Θ, char-
acterized by the uncertainty in parameter values. These uncertainty are
addressed though specification of prior probability distributions, as follows:
• µ1,j,...,K,j|λj,Σk ∼
∏K
k=1N(µj, σ
2
jλj) for means of xj in clusters {1, ..., K},
j = 1, ..., p
• µj ∼ N(0,∞) for common mean of xj, j = 1, ..., p
• λj ∼ Ga(c, d) for shrinkage parameter λj, j = 1, ..., p
• σ2j ∼ IG(r, s) for variance of xj, j = 1, ..., p
• w ∼ Dirichlet(α1, .., αK), for the mixture weight,
where Ga(.) and IG(.) denote the Gamma dan Inverse-Gamma distributions
respectively.
Introduction of shrinkage parameter λj is based on [43], in order to facili-
tate the selection of variables contributing to the clustering. Variables having
the group means µ1,j,...,K,j shrink towards a common value µj are considered
to be less relevant to form the clusters than other variables, and thus insight
into the role of each variable could be obtained upon comparison of these
parameters.
To avoid the issue of label switching [38], prior for the mean of falls
frequency, θ = exp(γ), for each cluster k is specified as
γ1 ∼ N(0, σ20),
and
γk = γk−1 + ηk−1, k = 2, ..., K
where ηk, k = 1, ..., K − 1, are assumed to follow a truncated normal dis-
tribution at 0, i.e. ηk ∼ N(0, σ20)I(0,∞). The indicator function I(0,∞) takes
the value 1 over the interval (0,∞) and 0 elsewhere. With this specification,
the labeling is inline with falls frequency, where cluster with smaller label
is associated with a group of patients with smaller frequency of falls. The
model is visualized in Figure 1.
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Figure 1: Directed Acyclic Graph representation of the FMM model. Σ = diag(σ21 , ..., σ
2
p).
Having specified the likelihood and the prior distributions, using the
Bayes rule, the complete data posterior is given by
p(pi,Φ, θ|x, y) ∝ likelihood× prior
= f(x, y|pi,Φ)× p(Φ)p(pi)
= f(x, y|pi,Φ)× p(µ|λ,Σ)p(λ)p(Σ)p(θ)p(pi)
= f(x, y|pi,Φ)×
p∏
j=1
[
N(µj, σ
2
jλj)p(λj)p(σ
2
j )
]
p(θ)p(pi) (8)
where f(x, y|pi,Φ) is the complete likelihood given in Equation 7 and the
corresponding densities for the prior are as listed above. Since there is no
closed form for the solution of this posterior density, samples are drawn from
the posterior distribution via MCMC.
We ran this model in WinBUGS [39], discarding the first 10,000 burn-in
iterations and sampling from the last 100,000 iterations. Exploratory data
analysis prior to fitting the mixture model and post analysis were conducted
in R [31]. Since the number of subgroups, K, is assumed unknown, we
fitted the models starting with K = 2 and iteratively increased the value
of K until a stopping criterion was met. The criterion is described in the
following section.
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2.3. Model diagnostics
Questions about the number of clusters and the quality of the representa-
tion of the data often arise upon implementing a FMM. When the number of
component is too large (i.e. overfitted mixture models), the overfitted latent
clusters will asymptotically become empty under specific conditions for the
prior of the class proportions [27, 35].
Various approaches have been proposed in the literature for choosing the
number of latent classes in mixture models. However, no consensus has
emerged regarding which of these methods performs best [27]. In this study,
we chose two commonly used criteria, Akaike’s Information Criterion (AIC)
[2]
AICk = −2logf(x, y|Θ) + 2νK ,
and the Bayesian Information Criterion (BIC) [37]
AICk = −2logf(x, y|Θ) + νK log(n).
Deviance component, −2logf(x, y|Θ), measures the fitness of the model
to data D = {x, y} given parameter Θ. The penalty term νK is set to control
the model’s complexity by accounting for the number of parameters required
to fully specify the model. Model with smaller values of AICK and BICK is
preferred.
2.4. Model inference
Once the number of subgroups is selected, the aim is to make an in-
ference on the unknown subgroup indicator, zi, and subgroup parameters
µk, σ
2
k representing the mean and variance of the corresponding symptoms
in subgroup k, and θk representing the associated fall frequency for patients
in subgroup k. These parameters provide information for further analysis
such as profile generation for each subgroup. Moreover, assessments on the
relevance and contribution of variables on the subgroup memberships will
also be undertaken.
2.4.1. Profile generation
Each subgroup was characterized by distinctive trends of subgroup at-
tributes (variables). Subgroup profiles were generated by describing the trend
of each variable through graphs of posterior distributions of the variable’s
mean in each subgroup. Furthermore, a summary of each variable , say x.j,
in each subgroup k in the form of mean µjk and standard deviation σjk will
also be inspected to characterize subgroups.
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2.4.2. Variable influence on subgroups membership
Given the subgroup profiles, it is of interest to assess the role of each vari-
able in assigning subjects into subgroups. Variable x.j is said to be relevant
to the subgrouping if its realizations are relatively homogeneous for subjects
in the same subgroup, and are different between subgroups. This relevance
measurement can be inferred through the shrinkage parameter λj introduced
in the model in Section 2.2. A high value of λj indicates that x.j is relevant
for the subgrouping, and vice versa. Thus, relevance can be interpreted as
the relative importance of variables governing the subgroups.
More insight into the role of each variable can be obtained through the
credible interval for the mean of each subgroup. The presence of non-
overlapping intervals between subgroups implies there are distinct charac-
teristics with respect to the corresponding variable.
In addition, there will be uncertainty about this mean which shoud be
considered when making comparisons. This uncertainty can be evaluated by
calculating the following:
D∗kk′ =
∑T
t=1 I{µ(t)k > µ(t)k′ }
T
. (9)
where T is the total number of MCMC iterations and I is the indicator
function which equals 1 when µk > µk′ and 0 otherwise. D
∗
kk′ measures
the consistency of the distribution of x.j to subgroup {k, k′}. D∗ near 0
or 1 implies homogeneity within subgroup and a good-separation between
subgroups.
To further assess a variable’s influence in forming subgroups, the sensi-
tivity of the posterior probabilities of subgroup membership with respect to
changes of a given variable is examined. The presence of noticeable changes
implies that the variable of interest is associated with the posterior proba-
bility of subgroup membership. Such sensitivities can also be examined via
the following odds ratio
Oddskk′ =
Pr(zi = k|xij)
Pr(zi = k′|xij) , (10)
which states the ratio between the posterior probability of being in subgroup
k and the posterior probability of being in subgroup k′ for patient i with the
characteristic xij. Odds > 1 suggests that patients with characteristic x.j are
more likely to be in subgroup k than in subgroup k′.
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3. Results
3.1. Description of participants and exploratory data
A summary of patients’ measurements and of patients classified as fallers
and non-fallers is given in Table 1. Data from 99 patients were used in
the analysis (66 males, 33 females, mean age 66.3 years). There was no
significant association between the demographics measurements and fall/non-
fall occurrences. Clear differences between fallers and non-fallers can be
observed in disease specific and functional tests measurements. We will not
elaborate more on these results. They are presented to show that there
are differences between fallers and non-fallers, and thus motivate further
elaboration on the corresponding measurements with fall frequency.
It is apparent that fall frequency increases over time, on average, as its
frequency in the 6-month follow-up is higher (mean 1.4) than that in the
previous year (mean 0.8). There were also patients who fell prior to partic-
ipating in the study (mean 0.3), yet did not fall during the follow-up. Fall
frequency for fallers in the previous year was almost 5 times higher than
that of non-fallers. This indicates that once patients fell, they were prone to
falling again.
The fall counts were examined and the result is depicted in Figure 2. The
plot shows a very high frequency for 0/1 fall counts, a peak in the middle then
low frequencies beyond a count of 5. The empirical density reveals multiple
peaks. With the assumption that data follows a Poisson distribution with
the mean equal to the fall count average, a QQ-plot was produced, see Figure
2. The plot, however, does not support the assumption, as many points are
off the line.
There are excess zero counts, i.e. 52% of the cohort did not fall. Ex-
cluding these zeros, the same process was then repeated and the result is
reproduced in Figure 3. The problem of multimodality still persists, and
thus, the assumption of a Poisson distribution for all of the data does not
appear valid. This motivates exploring whether there are underlying sub-
groups in the PD population, and thus motivates the consideration of profile
regression models, as presented in the following section.
3.2. Subgrouping via profile regression models
3.2.1. Model choice
Profile regression models were fitted with the mixture component (sub-
group) for the covariates ranging from 2 to 4. Based on the AICK and BICK
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Table 1: Summary of variables for study cohort at 6 months for all patients, and classified
by fallers and non-fallers. Variables in the first part of the table (top) are for patients
descriptions only (except Age). Variables for subgroup profiling are in the second part
of the table (bottom). Categorical variables are summarized by their frequency (%).
Numerical variables are summarized by their means. p-value is for between groups test
(Fallers and Non-fallers).
All patients Fallers Non-fallers p-value
Fall frequency
In the previous year 0.8 1.4 0.3 < .01
In 6 months of follow-up 1.4 3 0 < .01
Gender 0.5
Male 66 (67%) 38 (58%) 28 (42%)
Female 33 (33%) 15 (45 %) 18 (55 %)
Age 66.3 65.7 66.8 0.5
Height 168.7 168.6 168.7 0.98
Weight 72.8 74.5 71.4 0.31
Body mass index 25.6 26.2 25 0.24
MMSE 28 27.8 28.1 0.53
Schwab & England ADL 82.2 79.7 84.5 0.03
Hoehn & Yahr 0.19
1 27 (27%) 22 (81%) 5 (19%)
2 44 (44%) 20 (45%) 24 (55%)
3 28 (29%) 11 (39%) 17 (61%)
Disease specifics
Duration 6.2 7.3 5.3 0.05
UPDRS
Subtotal 1 2.4 2.8 2.1 0.16
Subtotal 2 10 11.5 8.8 0.01
Subtotal 3 18.9 21.3 16.8 0.03
PIGD 3.9 4.8 3 < .01
Freezing of gait 4.5 6.1 3.2 < .01
Functional tests
Tinetti total 25.9 24.8 26.8 < .01
Berg balance score 53.6 52.9 54.2 0.05
Timed up and go 9.9 10.5 9.3 0.03
Functional reach (best) 27.4 27.3 27.5 0.85
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Figure 2: Fall count bar plot, empirical density, and QQ-plot for all data.
Figure 3: Fall count bar plot, empirical density, and QQ-plot for data without zero fall
count.
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criteria as presented in Table 2, the model with three subgroups produced
the lowest values. Thus, further interpretation was based on this model. Fig-
ure 4a presents the fall counts for subjects in the three formed subgroups,
and the predicted counts (with 95% credible interval) for the replicated data
(Figure 4b). As indicated by the credible interval, fall counts are subgrouped
to three values, very low (0 or 1), low (less than 5), and high (greater than
5), which agrees with the fall count in Figure 3, implying the goodness of fit
of the model.
Table 2: Information criteria for the models with K subgroups.
Criteria Number of subgroups
2 3 4
AICK 7854 7728 7784
BICK 8007 7827 7961
3.2.2. Subgroup description
Three subgroups were formed as shown in Figure 4a, with the probability
of being in Subgroups 1 to 3 being 0.63, 0.27, and 0.08, respectively. Sub-
group 1 consists of patients who never fall or just experienced one fall (mean
fall counts = 0.5). The second subgroup is dominated by patients experienc-
ing one or two falls (mean fall counts = 1.48). Finally, more frequent fallers
were in Subgroup 3, with the mean fall counts of 10.61.
The relevance parameter measuring the relative importance of each vari-
able in assigning patients into the three subgroups is depicted in Figure 5.
According to this parameter, the length of time being diagnosed with the
disease (Duration) was least relevant for the subgrouping, and the Tinetti
total was the most relevant. Freezing of gait (FOG), timed up and go (TUG),
postural instability and gait difficulty (PIGD) and balance measured by Berg
balance score (BBS) shared a similar contribution to the patients’ subgroup-
ings as the relevance of these variables is about the same.
The posterior distribution of the means of variables was used to generate
the subgroup profiles (as depicted in Figures 6 and 7). Table 3 provides
more insight into the contribution of each variable to the subgrouping in the
form of credible intervals of posterior means and the degree of overlap of
these distributions. It can be inferred that Subgroup 1 and Subgroup 2 have
14
(a) (b)
Figure 4: Fall counts in three subgroups (a), Predicted fall counts with 95% credible
intervals for the replicated data (b) .
quite distinctive profiles based on several variables. Subgroup 3 on average is
quite different from the other subgroups, however, the variation in the means
is large, resulting in similar coverage values of the variables overall.
According to the disease specific measures (Figure 6), UPDRS subscales
II, III, and PIGD can classify patients in Subgroup 1 and Subgroup 2 clearly.
For UPDRS subscale I and FOG, there are slight overlaps between the two
subgroups. Interestingly, the distributions are more compact in subgroups
with lower fall frequency (shown by more peaked density), implying more
certainty in describing the non-or single-fallers than the frequent fallers. As
in this case, it is evident from the picture that Subgroup 3, the frequent
fallers, has a wide range of measures and thus cannot be differentiated with
the other subgroups. On the other hand, despite there being overlap, FOG
could differentiate between Subgroup 2 and Subgroup 3 more than other
disease-specific measures. The trend is: high scores of the UPDRS subscales
I, II, III and also of the PIGD, and worsening in freezing of gait, which
indicate deterioration of the patients’ condition represented by an increase
in fall frequency. As far as the disease duration is concerned, it does not
seem to be associated with the fall frequency.
As for the profiles based on functional tests measures (Figure 7), a similar
pattern with that of disease specific measures is shown: more compact dis-
tribution for posterior means of variables for Subgroup 1, clearer distinction
of Subgroup 1 and Subgroup 2, and wide coverage range of variables’ poste-
rior means for patients in Subgroup 3. Among these variables, Tinetti total,
15
Figure 5: Box plots of relative relevance of covariates used in subgrouping. Variables are
ordered in ascending relevance.
(a) (b) (c)
(d) (e) (f)
Figure 6: Profiles for the three subgroups -Subgroup 1 (dotted lines), Subgroup 2 (dashed
lines), and Subgroup 3 (solid lines)- based on disease-specific measures.
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TUG, and BBS best differentiated the first two subgroups. Moreover, Tinetti
total can also differentiate Subgroup 3 from the other subgroups clearly, rel-
ative to the other variables. It can be inferred from the figure that better
balance and gait (i.e. high scores on Tinetti and Berg balance tests) and
ease in movement (lower TUG, high FRB) were associated with lower fall
frequency, and vice versa.
(a) (b) (c)
(d) (e)
Figure 7: Profiles for the three subgroups -Subgroup 1 (dotted lines), Subgroup 2 (dashed
lines), and Subgroup 3 (solid lines)- based on functional tests and age.
As indicated in Table 1, there was no significant difference in age (on
average) between fallers and non-fallers. Further insight is provided by the
mixture model, as depicted in Figure 7e. Non-or single-fallers were rela-
tively younger than low-frequency fallers. The non-association of age and
fallers/non-fallers stated earlier was due to the contribution from recurrent
fallers, whose age range covered the range for the first two subgroups. Thus,
when patients were only classified as fallers or non-fallers, the age was not
greatly different between the two subgroups.
The profile for each subgroup is summarized in Table 3. The disease-
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specific measurements were able to differentiate Subgroup 1 and Subgroup 2
clearly, shown by non-overlapping of credible intervals of the posterior means
of these variables (except for Duration). UPDRS subscales II and III, PIGD,
Tinetti total, Berg balance, and timed up and go scores were completely dif-
ferent for the two subgroups. The degree of uncertainty measurement also
provides a similar conclusion as many values of D∗12 are either close to 0 or
1. The proportion of Subgroup 1 with the mean value of the corresponding
variable is greater than that of Subgroup 2 is close to 0, or the opposite. How-
ever, these variables cannot clearly differentiate between patients with low
fall frequency (Subgroup 2) and patients with high fall frequency (Subgroup
3).
Functional test variables also show similar role to disease-specific test
variables in the subgroups. These variables were very different in Subgroup 1
and Subgroup 2, and not greatly different between Subgroup 2 and Subgroup
3.
However, further insight into D∗23 shows that the Tinetti total, Berg bal-
ance score and freezing of gait could identify Subgroups 2 and 3 relatively
well compared to the other variables. Furthermore, the Tinetti total and
Berg balance score have a consistent, negative association with fall frequency
(D∗12 = 1, D
∗
23 ≈ 1), which means good balance (measured by high score of
the Tinetti total and BBS) is associated with less falls. As for FOG, D∗23 ≈ 0
means that patients in Subgroup 2 have a lower freezing of gait score than
patients in Subgroup 3. Adding the information of D∗12 ≈ 0 for freezing of
gait shows its consistent negative association with falls.
3.2.3. Uncertainty in subgroup membership
Given the subgroup profiles and relative importance of each variable, it
is of interest to assess how variables determine the subgroup membership.
Therefore, some variables were modified (by changing particular values, as
summarized in Table 4), and the changes in subgroup membership were
evaluated. Five modifications were implemented, and the results are shown
in Figure 8.
Considering the distinct separation of values of functional tests for Sub-
group 1 and Subgroup 2 as described in the previous subsection, it is surpris-
ing that Patient 2 is assigned to Subgroup 1 (Figure 8b). However, there is a
slight change in the density of the posterior probability of membership from
Patient 1 to Patient 2 (Figures 8a, 8b), indicating a subtle effect of functional
tests on subgroup membership. A more noticeable result is obtained when
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Table 3: Posterior means and 95% credible intervals and comparison of mean differences
between subgroups for each variable. Disjoint intervals are in bold. D∗ij is for comparing
Subgroup i and Subgroup j.
Subgroup 1 Subgroup 2 Subgroup 3 D∗12 D
∗
23
Age 64.3 (62.3, 66.3) 70.1 (67.2, 73) 65.8 (58.3, 74) .0023 .7972
Disease-specifics
UPDRS I 1.7 (1.2, 2.3) 3.5 (2.6, 4.3) 4 (1.4, 6.4) .0006 .4695
UPDRS II 7.8 (6.7, 8.9) 13.7 (11.9, 15.4) 13.5 (8.4, 18.2) 0 .584
UPDRS III 15 (12.9, 17.2) 25.3 (22.1, 28.6) 26.8 (17.9, 36.6) 0 .334
PIGD 2.4 (1.9, 3) 6.3 (5.4, 7.1) 6.1 (3.8, 8.6) 0 .5052
Freezing of gait 3 (2, 4.1) 6.6 (5.1, 8.2) 11.1 (6.6, 16) .0004 .0238
Duration 6 (4.8, 7.2) 6.4 (4.8, 8.1) 6.7 (2.1, 11.1) .3211 .4852
Functional tests
Tinetti Total 26.8 (26.1, 27.4) 24.6(23.7, 25.6) 22.7 (19.8, 25.3) 1 .9816
Berg balance score 54.6 (54, 55.3) 52.1 (51.1, 53) 49.4 (45.9, 52.9) 1 .9227
Functional reach (best) 29.1 (27.4, 30.7) 24.6 (22.3, 26.8) 25.2 (19, 31.7) .9974 .4278
Timed up & go 8.7 (8.2, 9.2) 11.8 (11, 12.6) 12 (9.9, 14.4) 0 .3898
Table 4: Variable modification to assess the uncertainty in subgroup membership. Patient
1 is the reference.
Patient Modified variables
1 Values for age and duration diagnosed, were set to the mean for all data
Other variables were set to the corresponding means for Subgroup 1.
2 Change values for Functional test variables to their Subgroup 2 means.
3 Change values for disease-specific variables to their Subgroup 2 means.
4 Change values for Functional tests and disease-specific variables to their Subgroup 2 means.
5 Selected variables from Patient 4.
(a) (b) (c) (d) (e)
Figure 8: Empirical densities of posterior probability membership for each patient de-
scribed in Table 4 (solid line = subgroup 1, dashed line = subgroup 2). Subgroup 3 is not
presented as the probability is almost zero for all modifications.
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the disease-specific measures are changed (Patient 1 to Patient 3), as shown
by the posterior probability of assigning Patient 3 to Subgroup 2 (Figures 8a,
8c). When both functional tests and disease-specific measures are changed
(Patient 4), a more certain subgroup assignment is yielded (Figure 8d). Con-
sidering the overlap in the distribution of some measures for Subgroup 1 and
Subgroup 2, omission of these variables (UPDRS I and FRB) does not change
the subgroup assignment as shown for Patient 5.
It can be inferred from Figure 8 that the contribution of disease-specific
measures is stronger than that of functional tests in subgrouping -and thus
in predicting fall frequency- as changes in the empirical density for Patient
1 (Figure 8a) to that for Patient 3 (Figure 8c) is greater than changes for
Patient 2 (Figure 8b). The effect of functional tests is noticeable when it is
adjusted with the disease-specific measures (with more compact density in
Figure 8d compared to Figure 8c).
As for the individual instrument measures, changing the value of one
measure did not greatly change the posterior probability of subgroup mem-
bership (graphs not shown). However, to assess the effect of the functional
tests, the odds of being in either Subgroup 1 or Subgroup 2 were calculated
as the selected variable changes relative to the reference value. Balance and
gait represented by the Tinetti total score was modified, taking all possible
values (1 to 28), and the odds are presented in Figure 9.
It is shown that a patient having good balance and gait (high Tinetti
total score) is more likely to be in Subgroup 1 than Subgroup 2, and vice
versa. As the Tinetti total score increases, the odds of being in Subgroup 1
increases faster when other measures are set to Subgroup 2 means (Figure 9c)
than when they are set to Subgroup 1 means (Figure 9a). The opposite
trend occurs for the odds of being in Subgroup 2 (Figures 9b and 9d). This
demonstrates the association between the Tinetti and other variables used
in this model.
When changing more variables- timed up and go (TUG) scores - the
changes in subgroup membership are more noticeable, as represented by the
odds depicted in Figure 10. As the Tinetti total and TUG scores reflect a
better condition for the patient (higher Tinetti total, lower TUG), the odds
of being in Subgroup 1 increased greatly although the other variables were
set to Subgroup 2 means, representing a worse condition than Subgroup 1,
(Figure 10c compared to Figure 10a). Under the same scenario, the odds of
being in Subgroup 2 also diminished rapidly (Figure 10b compared to Figure
10d).
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(a) (b) (c) (d)
Figure 9: Odds of being in Subgroup 1 (a) and Subgroup 2 (b) when Tinetti total score
is increased and all other variables were set to Subgroup 1 means. When other variables
were set to Subgroup 2 means, the corresponding odds are as in (c) and (d).
Figure 10: Odds of being in Subgroup 1 (a) and Subgroup 2 (b) when the Tinetti total
score is increased and TUG score is decreased, all other variables were set to Subgroup 1
means. When other variables were set to Subgroup 2 means, the corresponding odds are
as in (c) and (d).
3.2.4. Sensitivity analysis
Two distibutions were chosen for the prior of mixture weight pi: Dirichlet
distribution and the multinomial logit model with a parameter which follows
a Normal distribution. For an FMM with three classes, an uninformative
Dirichlet distribution is given by α = (1, 1, 1). Denote this as Prior 1. For
Prior 2, the following multinomial logit model was considered
pik =
exp(γk)∑
k exp(γk)
, (11)
with γ1 = 0, γk ∼ N(0, 1) for k = 2, 3. A condition of γ1 ≤ γ2 ≤ γ3 was set to
address the problem of label switching. The posterior distribution obtained
given each prior is shown in Figure 11.
Both priors produced similar posterior estimates for the mixture weights,
indicated by the overlapping graphs of the posterior density of the mixture
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weights. This shows that the results are robust to the choice of prior for the
mixture weight.
(a) (b)
(c)
Figure 11: Posterior density of mixture weights for FMM with three subgroups:(a) Sub-
group 1, (b) Subgroup 2, and (c) Subgroup 3. The red lines represent the Dirichlet prior
and the green lines represent the multinomial logit prior.
4. Discussion
In this paper, we have demonstrated generating profiles for subgroups of
patients with early stages of PD via profile regressions. Variables measuring
functional and disease specific assessments were assumed to follow a Gaussian
distribution, while a Poisson distribution was assumed for fall frequency.
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Three subgroups representing non- or single- fallers, low frequency fallers,
and high frequency fallers were formed. Profiles characterizing each subgroup
were also generated. Distinctive characteristics were identified between non-
or single-fallers and low frequency fallers, while this was not the case for
the high frequency fallers. For the high frequency fallers, this result needs
a cautious interpretation due to the small number of cases assigned to this
subgroup.
The subgroups with a higher fall frequency have wide coverage for each
of the measures. This indicates that, in the early stage of PD, patients with
recurrent falls cannot be differentiated from those with a low frequency of
falls. Even for the duration diagnosed, there are patients who were diagnosed
for a shorter time but who experienced more falls (being in Subgroup 3) than
other patients. This suggests the possibility of unknown factors that need
to be examined to shed light on this problem. Further, it might imply that
once a patient has experienced a fall, they are prone to experience recurrent
falls, regardless of other conditions represented by the above measures.
Further, this suggests that it might be useful to identify risk factors as-
sociated with the first fall, as potentially it may be more beneficial to try to
prevent that first fall rather than repeated falls. Variables that differentiate
Subgroup 1 from the other subgroups offer potential to be associated with
the occurrence of the first fall. The posterior density of the subgroup means
reveals that the FOG, PIGD, Tinetti total and BBS are the potential risk
factors for the first fall, with the Tinetti total as the strongest associated
factor.
Modifying only one variable did not change the subgroup assignment
greatly. Thus, to assess the contribution of measures to subgroup member-
ship, we modified the variables based on the disease-specific or functional
tests measures. Functional test variables can differentiate well between non
-or single- fallers with low frequency fallers, showing the usefulness of these
measures in subgrouping the patients. However, only changing these vari-
ables had little effect on the subgroup without the change of the disease-
specific measures, as has been demonstrated in Section 3.2. This confirmed
the order of importance of the variable, where functional tests are needed to
enhance the information from disease-specific measures.
Furthermore, functional tests can differentiate low frequency fallers from
high frequency fallers better than disease-specific measures, as the posterior
probability distribution of subgroup membership for the Tinetti total and
Berg balance score had the least overlap between the two subgroups. The
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model with Tinetti balance and Tinetti gait as replacements to the Tinetti
total was also fitted (results not shown). Tinetti balance separated Subgroup
1 and Subgroup 2 very well, but did not differentiate Subgroup 3 from the
other two subgroups. Interestingly, Tinetti gait does not separate Subgroup
1 and Subgroup 2 as well as Tinetti balance (there was an overlap between
the posterior probability distribution between the two subgroups). Instead,
it had the least overlap between Subgroup 2 and Subgroup 3 compared to
all other measures, indicating the ability of Tinetti gait to identify high
frequency fallers more accurately than other variables.
Upon examining the contribution of individual variables towards sub-
group membership, the Tinetti was chosen as the measure to modify. Differ-
ent rates of change on the odds of being in either Subgroup 1 or Subgroup 2
when other variables were set differently indicates the dependency of Tinetti’s
effect on other variables. When the patient’s condition was relatively healthy
(as other variable values were set to Subgroup 1 means), a worsening in bal-
ance and gait did not change the subgroup membership. However, when the
condition becomes worse (changing the values to Subgroup 2 means), the
change in the Tinetti produced a noticeable effect on the subgroup member-
ship.
This might imply that the variables change simultaneously, that is, a
change in one variable would also imply a change in other variables. Thus
we cannot infer the impact of one variable alone in assessing the patients’ con-
ditions. Another implication is that as the patients’ conditions degenerate,
slight changes of one variable could impact on their subgroup membership
(which implies an increased risk of falls).
For Tinetti, the change in subgroup membership is more explained by
the balance test than the gait test in the subgroups of non-or single-fallers
and low frequency fallers. The gait test gave a better explanation than the
balance test when comparing low and high frequency fallers. Adding the
TUG to the modification supported the results.
An early study by [14] generated profiles for PD patients based on neu-
ropsychological measurements, while subgroups based on the tendency to-
wards delusions and hallucinations were examined in [3]. A recent profiling
study by [1] focused on the cognitive aspect of the disease. The results from
this study provides insight into the composition of the PD population. The
inclusion of fall frequency in tandem with other clinical measurements allow
profiles to be generated and assessed against trends and characteristics ob-
served in other variables. This provided additional insight into understanding
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the variability within a PD population.
5. Summary
Through this research study, we have identified three subgroups of pa-
tients with early stage PD, based on fall frequency, disease-specific measure-
ments, and functional test measurements. Profiles for each subgroup were
generated. Inclusion of fall frequency harnesses insight into each subgroup,
namely non-or single-fallers (Subgroup 1), low frequency fallers (Subgroup
2), and high frequency fallers (Subgroup 3). Thus, a tailored treatment could
be recommended based on these profiles to help prevent the deterioration of
patients condition (i.e. further falls).
Using disease-specific variables, a clear differentiation of Subgroup 1 and
Subgroup 2 is observed. However, these variables could not differentiate
Subgroup 2 and Subgroup 3 very well. On the other hand, functional test
variables were able to differentiate the 3 subgroups clearly. However, a com-
parison of disease specific variables and functional test variables in affecting
the subgroup assignment of patients showed that the former have a higher
contribution to the subgrouping than the latter. Thus, it is inferred that
disease-specific measures are significant and sensitive enough to differenti-
ate PD patients with no-or single-falls from patients with low fall frequency.
Once patients have experienced at least one fall, functional tests comple-
ment the disease specific measures to signify low frequency fallers from high
frequency fallers. Thus, a tailored treatment focusing on disease-specific fac-
tors could be designed to prevent the first fall, or to prevent further falls for
patients who have just had one fall. For patients with recurrent falls, falls
preventive treatment could be based on functional test factors.
References
[1] Sikandar Adwani, Ravi Yadav, Keshav Kumar, SR Chandra, and
Pramod Kumar Pal. Neuropsychological profile in early Parkinson’s
disease: Comparison between patients with right side onset versus left
side onset of motor symptoms. Annals of Indian Academy of Neurology,
19(1):74, 2016.
[2] Hirotugu Akaike. Factor analysis and AIC. Psychometrika, 52(3):317–
332, 1987.
25
[3] BR Amar, Ravi Yadav, YC Janardhan Reddy, and Pramod Kumar Pal.
A clinical profile of patients with Parkinson’s disease and psychosis.
Annals of Indian Academy of Neurology, 17(2):187, 2014.
[4] Bastiaan R Bloem and Kailash P Bhatia. Gait and balance in basal
ganglia disorders. 2004.
[5] Bastiaan R Bloem, Yvette AM Grimbergen, Monique Cramer, Mirjam
Willemsen, and Aeilko H Zwinderman. Prospective assessment of falls
in Parkinson’s disease. Journal of Neurology, 248(11):950–958, 2001.
[6] Mar´ıa Moreno Catala´, Dirk Woitalla, and Adamantios Arampatzis. Re-
covery performance and factors that classify young fallers and non-fallers
in Parkinson’s disease. Human Movement Science, 41:136–146, 2015.
[7] Kathy Dujardin, Luc Defebvre, Alain Duhamel, Pascal Lecouffe, Pascal
Rogelet, Marc Steinling, and Alain Deste´e. Cognitive and spect char-
acteristics predict progression of Parkinson’s disease in newly diagnosed
patients. Journal of Neurology, 251(11):1383–1392, 2004.
[8] Ryan P Duncan, James T Cavanaugh, Gammon M Earhart, Terry D
Ellis, Matthew P Ford, K Bo Foreman, Abigail L Leddy, Serene S Paul,
Colleen G Canning, Anne Thackeray, et al. External validation of a
simple clinical tool used to predict falls in people with Parkinson disease.
Parkinsonism & Related Disorders, 2015.
[9] M Flensborg Damholdt, Mark Shevlin, Per Borghammer, Lars Larsen,
and Karen Østergaard. Clinical heterogeneity in Parkinsons disease
revisited: a latent profile analysis. Acta Neurologica Scandinavica,
125(5):311–318, 2012.
[10] E Gasparoli, D Delibori, G Polesello, L Santelli, M Ermani, L Battistin,
and F Bracco. Clinical predictors in Parkinson’s disease. Neurological
Sciences, 23:s77–s78, 2002.
[11] Tatjana Gazibara, Tatjana Pekmezovic, Darija Kisic-Tepavcevic, Ma-
rina Svetel, Aleksandra Tomic, Iva Stankovic, and Vladimir S Kostic.
Incidence and prediction of falls in Parkinson’s disease: a prospective
cohort study. European Journal of Epidemiology, 30(4):349–352, 2015.
26
[12] Richard W Genever, Thomas W Downes, and Pippa Medcalf. Fracture
rates in Parkinson’s disease compared with age-and gender-matched con-
trols: a retrospective cohort study. Age and Ageing, 34(1):21–24, 2005.
[13] Jacqueline M Graham and Harvey J Sagar. A data-driven approach
to the study of heterogeneity in idiopathic Parkinson’s disease: identi-
fication of three distinct subtypes. Movement Disorders, 14(1):10–20,
1999.
[14] Carmen Janvin, Dag Aarsland, Jan P Larsen, and Kenneth Hugdahl.
Neuropsychological profile of patients with Parkinsons disease without
dementia. Dementia and Geriatric Cognitive Disorders, 15(3):126–131,
2003.
[15] Angie A Kehagia, Roger A Barker, and Trevor W Robbins. Neuropsy-
chological and clinical heterogeneity of cognitive impairment and de-
mentia in patients with Parkinson’s disease. The Lancet Neurology,
9(12):1200–1213, 2010.
[16] GK Kerr, Charles J Worringham, Michael H Cole, Philippe F Lacherez,
Joanne M Wood, and PA Silburn. Predictors of future falls in Parkin-
son’s disease. Neurology, 75(2):116–124, 2010.
[17] Mark D Latt, Stephen R Lord, John GL Morris, and Victor SC Fung.
Clinical and physiological assessments for elucidating falls risk in Parkin-
son’s disease. Movement Disorders, 24(9):1280–1289, 2009.
[18] SJG Lewis, T Foltynie, AD Blackwell, TW Robbins, AM Owen, and
RA Barker. Heterogeneity of Parkinson’s disease in the early clinical
stages using a data driven approach. Journal of Neurology, Neurosurgery
& Psychiatry, 76(3):343–348, 2005.
[19] Beata Lindholm, Peter Hagell, Oskar Hansson, and Maria H Nilsson.
Prediction of falls and/or near falls in people with mild Parkinson’s
disease. PloS one, 10(1):e0117018, 2015.
[20] Ping Liu, Tao Feng, Yong-jun Wang, Xuan Zhang, and Biao Chen.
Clinical heterogeneity in patients with early-stage Parkinson’s disease:
a cluster analysis. Journal of Zhejiang University Science B, 12(9):694–
703, 2011.
27
[21] Silvia Liverani, David I Hastie, Lamiae Azizi, Michail Papathomas, and
Sylvia Richardson. PReMiuM: an R package for profile regression mix-
ture models using Dirichlet processes. Journal of Statistical Software,
64(7):1, 2015.
[22] Margaret KY Mak and Marco YC Pang. Parkinsonian single fallers
versus recurrent fallers: different fall characteristics and clinical features.
Journal of Neurology, 257(9):1543–1551, 2010.
[23] Connie Marras and Anthony Lang. Parkinson’s disease subtypes: Lost
in translation? Journal of Neurology, Neurosurgery & Psychiatry,
84(4):409–415, 2013.
[24] Krisna McCoy. Recognizing the stages of Parkinson’s disease progres-
sion, April 2016.
[25] Geoffrey McLachlan and David Peel. Finite mixture models. John Wiley
& Sons, 2004.
[26] John Molitor, Michail Papathomas, Michael Jerrett, and Sylvia Richard-
son. Bayesian profile regression with an application to the National
Survey of Children’s Health. Biostatistics, 11(3):484–498, 2010.
[27] Kazem Nasserinejad, Joost van Rosmalen, Wim de Kort, and Emmanuel
Lesaffre. Comparison of criteria for choosing the number of classes in
Bayesian finite mixture models. PLoS ONE, 12(1):e0168838, 2017.
[28] Serene S Paul, Colleen G Canning, Catherine Sherrington, Stephen R
Lord, Jacqueline CT Close, and Victor SC Fung. Three simple clini-
cal tests to accurately predict falls in people with Parkinson’s disease.
Movement Disorders, 28(5):655–662, 2013.
[29] Ruth M Pickering, Yvette AM Grimbergen, Una Rigney, Ann Ashburn,
Gordon Mazibrada, Brian Wood, Peggy Gray, Graham Kerr, and Bas-
tiaan R Bloem. A meta-analysis of six prospective studies of falling in
Parkinson’s disease. Movement Disorders, 22(13):1892–1900, 2007.
[30] Bart Post, Johannes D Speelman, Rob J De Haan, CARPA-Study
Group, et al. Clinical heterogeneity in newly diagnosed Parkinson’s
disease. Journal of Neurology, 255(5):716–722, 2008.
28
[31] R Core Team. R: A Language and Environment for Statistical Comput-
ing. R Foundation for Statistical Computing, Vienna, Austria, 2015.
[32] JSAM Reijnders, U Ehrt, R Lousberg, D Aarsland, and AFG Leent-
jens. The association between motor subtypes and psychopathology in
Parkinson’s disease. Parkinsonism & Related Disorders, 15(5):379–382,
2009.
[33] Margaret Rolfe, Nicole White, and Carla Chen. Latent class models in
medicine. 2012.
[34] Diana Helen Romero and George E Stelmach. Changes in postural con-
trol with aging and Parkinson’s disease. IEEE Engineering in Medicine
and Biology Magazine, 22(2):27–31, 2003.
[35] Judith Rousseau and Kerrie Mengersen. Asymptotic behaviour of the
posterior distribution in overfitted mixture models. Journal of the Royal
Statistical Society: Series B (Statistical Methodology), 73(5):689–710,
2011.
[36] A Schrag, NP Quinn, and Y Ben-Shlomo. Heterogeneity of Parkinson’s
disease. Journal of Neurology, Neurosurgery & Psychiatry, 77(2):275–
276, 2006.
[37] Gideon Schwarz et al. Estimating the dimension of a model. The Annals
of Statistics, 6(2):461–464, 1978.
[38] Matthew Stephens. Dealing with label switching in mixture models.
Journal of the Royal Statistical Society: Series B (Statistical Methodol-
ogy), 62(4):795–809, 2000.
[39] Andrew Thomas. BUGS: A statistical modelling package. RTA/BCS
Modular Languages Newsletter, 2:36–38, 1994.
[40] Stephanie M van Rooden, Fabrice Colas, Pablo Mart´ınez-Mart´ın, Mar-
tine Visser, Dagmar Verbaan, Johan Marinus, Ray K Chaudhuri,
Joost N Kok, and Jacobus J van Hilten. Clinical subtypes of Parkinson’s
disease. Movement Disorders, 26(1):51–58, 2011.
29
[41] Nicole White, Helen Johnson, Peter Silburn, George Mellick, Nadeeka
Dissanayaka, and Kerrie Mengersen. Probabilistic subgroup identifica-
tion using Bayesian finite mixture modelling: A case study in Parkin-
son’s disease phenotype identification. Statistical Methods in Medical
Research, 21(6):563–583, 2012.
[42] BH Wood, JA Bilclough, A Bowron, and RW Walker. Incidence and
prediction of falls in Parkinson’s disease: A prospective multidisciplinary
study. Journal of Neurology, Neurosurgery & Psychiatry, 72(6):721–725,
2002.
[43] C Yau and C Holmes. Hierarchical Bayesian nonparametric mixture
models for clustering with variable relevance determination. Bayesian
Analysis, 6(2):329–352, 2011.
30
